Methodology

Direct Chemiluminescent Assay

Used in detection of early-stage prostate cancer in conjunction with digital rectal examination, and for indicating tumor recurrence and response to therapy for patients with a history of prostate cancer.

Note:  The PSA assay should not be used as a cancer screening test. It is not an absolute test for malignancy and should be used in conjunction with information available from clinical evaluation and other diagnostic procedures.